BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6252 related articles for article (PubMed ID: 329910)

  • 1. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene in melanin-containing tissues.
    Roberto A; Larsson BS; Tjälve H
    Pharmacol Toxicol; 1996 Aug; 79(2):92-9. PubMed ID: 8878252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in disseminated malignant melanoma.
    Kleeberg UR
    Anticancer Res; 1987; 7(3 Pt B):423-7. PubMed ID: 3307600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of hematogenously disseminated allogeneic tumor cells in athymic nude mice.
    Fidler IJ; Caines S; Dolan Z
    Transplantation; 1976 Aug; 22(2):208-12. PubMed ID: 968936
    [No Abstract]   [Full Text] [Related]  

  • 5. The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma: prognosis versus efficacy, toxicity and costs.
    Eggermont AM
    Melanoma Res; 1997 Aug; 7 Suppl 2():S127-31. PubMed ID: 9578428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the mechanism of cancer metastasis by using anticancer agents].
    Ozaki A; Saijo N; Beppu Y; Takahashi K; Shimizu E; Kimata M; Hoshi A
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):279-84. PubMed ID: 6421247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neoplastic activity of C205: a new topical anti-cancer formulation.
    Pardini RS; Jordan RT
    Cancer Lett; 1984 Jul; 23(3):273-7. PubMed ID: 6744251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous and induced differentiation of human melanoma cells.
    Valyi-Nagy I; Shih IM; Györfi T; Greenstein D; Juhasz I; Elder DE; Herlyn M
    Int J Cancer; 1993 Apr; 54(1):159-65. PubMed ID: 8478142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
    De Martino C; Battelli T; Cavaliere R; Gallo Curcio C; Bellocci M; Manocchi D; Giustini L; Mattioli R; Rinaldi M; Di Filippo F
    Oncology; 1984; 41 Suppl 1():94-103. PubMed ID: 6717904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
    Cochran AJ; Pihl E; Wen DR; Hoon DS; Korn EL
    J Natl Cancer Inst; 1987 Mar; 78(3):399-405. PubMed ID: 3469453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation.
    Zimmerman LE; McLean IW; Foster WD
    Ophthalmology; 1980 Jun; 87(6):557-64. PubMed ID: 7413145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
    Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
    Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.
    Fleischhauer K; Fruci D; Van Endert P; Herman J; Tanzarella S; Wallny HJ; Coulie P; Bordignon C; Traversari C
    Int J Cancer; 1996 Nov; 68(5):622-8. PubMed ID: 8938145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy applied to melanoma].
    Dreno B
    Ann Dermatol Venereol; 1995; 122(4):235-40. PubMed ID: 8526418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal melanomas near the optic disk or macula. Long-term results after proton beam irradiation: a report of 3 cases.
    Zehetmayer M; Menapace R
    Ophthalmologica; 1993; 206(1):18-23. PubMed ID: 8278155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
    Chirivi RG; Garofalo A; Crimmin MJ; Bawden LJ; Stoppacciaro A; Brown PD; Giavazzi R
    Int J Cancer; 1994 Aug; 58(3):460-4. PubMed ID: 8050828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous epithelioid angiosarcoma: a clinicopathological study of four cases.
    Prescott RJ; Banerjee SS; Eyden BP; Haboubi NY
    Histopathology; 1994 Nov; 25(5):421-9. PubMed ID: 7868082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of 3 cm excision margin for melanoma of the scalp.
    Hudson DA; Krige JE
    J R Coll Surg Edinb; 1995 Apr; 40(2):93-6. PubMed ID: 7776282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct analysis of tumor-associated peptide antigens.
    Slingluff CL; Hunt DF; Engelhard VH
    Curr Opin Immunol; 1994 Oct; 6(5):733-40. PubMed ID: 7530012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of a lymphotoxin-like mediator in peripheral blood and synovial fluid lymphocytes by incubation with synovial fluid from patients with rheumatoid arthritis.
    Burmester GR; Beck P; Eife R; Peter HH; Kalden JR
    Rheumatol Int; 1981; 1(3):139-43. PubMed ID: 6981184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 313.